Pharmaceutical Lawsuit and Recall Information
At RxRecall.com, our pharmaceutical litigation and defective drug lawyers are committed to serving personal injury victims and are well versed in the product liability laws that protect consumers.
A jury awarded Gillian Gaghan $2million in damages in the closely watched Accutane trial in New Jersey. She developed ulcerative colitis and lupus-like symptoms after using the acne medicine. The jury found that the Accutane side effects were indeed responsible for her intestinal disorder and that she did not have adequate warnings and information when [...]
The British Medical Journal recently published studies that looked at the rate of blood clots in users of Yaz and Yasmin which contain a synthetic hormone called drospirenone compared it users of older birth control pills that contain levonorgestrel. Researchers found that women on Yaz or Yasmin had more than double the risk of blood [...]
Propecia and Proscar is made by pharmaceutical giant, Merck and is often prescribed for male pattern baldness and enlarged prostate or benign prostatic hyperplasia (BPH). The active ingredient in both drugs is finasteride. Propecia is the brand name of the 1-milligram tablet and Proscar is the 5-milligramt tablet. Merck lists known serious side effects: cognitive [...]
There is conflicting and confusing information regarding the dangers to fetuses when exposed to Proton Pump Inhibitor medication, or PPI. These types of medications include Nexium, Dexilant, Prilosec, Zegerid, Protonix and Prevacid among others. The question has been examined by the New England Journal of Medicine (NEJM). Last November researchers published a report suggesting that [...]
Amid a flurry of Yaz lawsuits, Bayer Healthcare, eager to hold its top spot in the oral contraceptive market, launched a new birth control pill last year… Natazia. Bayer cleverly launched Yaz in 2006, promising that the new formulation birth control pill – a combination of ethinyl estradiol and drospirenone – not only prevented pregnancy [...]
A new report from Paxil’s maker, GlaxoSmithKline, concludes that its popular antidepressant Paxil might make adults with major depression more likely to become suicidal. According to Sarah Alspach, a spokeswoman for the drug company, “all patients who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual [...]
